No Data
No Data
Human T, Cygenia, etc.
<2160>Preparing to apply for a market classification change to the GNI Tokyo Stock Exchange Prime Market signed a business alliance (strategic partnership agreement) with Governance Partners, which handles the recruitment and management of investment funds Ortz, which handles P.A.I. (personal artificial intelligence) research and development, etc., established a joint venture with Governance Partners <3691>Digital Plus earnings forecast revised, operating profit forecast 0.25 billion yen ←△ 102 million yen <4068>Basis Downward revisions, current operating profit
Carna Biosciences: Extraordinary Report
Carna Biosciences: Confirmation
Carna Biosciences: Quarterly Report - 22nd Term 1st Quarter (2024/01/01 - 2024/03/31)
Carna Biosciences 1Q Loss Y398.00M Vs Loss Y519.00M
Carna Biosciences Inc. (4572.TO) Japan 1st Quarter Ended March 31 GROUP 2024 2023 Revenue Y180.00 mln Y226.00 mln Operating Profit (Y416
Carna Biosciences: Financial results presentation for the 1st quarter of the fiscal year ending 2024/12
No Data